DLDYX
Price
$46.49
Change
+$0.24 (+0.52%)
Updated
Jan 17 closing price
Net Assets
1.3B
TRNEX
Price
$39.94
Change
+$0.28 (+0.71%)
Updated
Jan 17 closing price
Net Assets
2.49B
Ad is loading...

DLDYX vs TRNEX

Header iconDLDYX vs TRNEX Comparison
Open Charts DLDYX vs TRNEXBanner chart's image
BNY Mellon Natural Resources Y
Price$46.49
Change+$0.24 (+0.52%)
VolumeN/A
Net Assets1.3B
T. Rowe Price New Era I
Price$39.94
Change+$0.28 (+0.71%)
VolumeN/A
Net Assets2.49B
DLDYX vs TRNEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DLDYX vs. TRNEX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLDYX is a Buy and TRNEX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
TRNEX has more cash in the bank: 2.49B vs. DLDYX (1.3B). TRNEX pays higher dividends than DLDYX: TRNEX (2.97) vs DLDYX (2.28). DLDYX was incepted earlier than TRNEX: DLDYX (9 years) vs TRNEX (9 years). DLDYX is a more actively managed with annual turnover of: 89.32 vs. TRNEX (82.80). TRNEX has a lower initial minimum investment than DLDYX: TRNEX (500000) vs DLDYX (1000000). TRNEX annual gain was more profitable for investors over the last year : 15.17 vs. DLDYX (6.93). DLDYX return over 5 years is better than : 58.39 vs. TRNEX (30.92).
DLDYXTRNEXDLDYX / TRNEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years9 years-
Gain YTD6.1667.62681%
Front LoadN/AN/A-
Min. Initial Investment1000000500000200%
Min. Initial Investment IRAN/AN/A-
Net Assets1.3B2.49B52%
Annual Yield % from dividends2.282.9777%
Returns for 1 year6.9315.1746%
Returns for 3 years1.876.6228%
Returns for 5 years58.3930.92189%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WMG30.240.21
+0.70%
Warner Music Group Corp
TYRA16.190.04
+0.25%
Tyra Biosciences
REZI22.96-0.06
-0.26%
Resideo Technologies
IKT2.72-0.04
-1.45%
Inhibikase Therapeutics
BMRA0.64-0.07
-9.35%
Biomerica